Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 264.6 Million USD | 68.56% |
| 2023 | 156.98 Million USD | 794.37% |
| 2022 | 17.55 Million USD | 321.89% |
| 2021 | 4.16 Million USD | -41.23% |
| 2020 | 7.07 Million AUD | 8.23% |
| 2019 | 6.54 Million AUD | -17.24% |
| 2018 | 7.9 Million AUD | 285.02% |
| 2017 | 2.05 Million AUD | -1.05% |
| 2016 | 2.07 Million AUD | 15.03% |
| 2015 | 1.8 Million AUD | -3.36% |
| 2014 | 1.86 Million AUD | -0.4% |
| 2013 | 1.87 Million AUD | -23.98% |
| 2012 | 2.46 Million AUD | -13.9% |
| 2011 | 2.86 Million AUD | 18.25% |
| 2010 | 2.42 Million AUD | 19.69% |
| 2009 | 2.02 Million AUD | -13.55% |
| 2008 | 2.33 Million AUD | -53.2% |
| 2007 | 4.99 Million AUD | 190.63% |
| 2006 | 1.71 Million AUD | -59.9% |
| 2005 | 4.28 Million AUD | 1273.22% |
| 2004 | 312.33 Thousand AUD | -1.86% |
| 2003 | 318.25 Thousand AUD | 52.37% |
| 2002 | 208.87 Thousand AUD | 25.94% |
| 2001 | 165.84 Thousand AUD | -23.95% |
| 2000 | 218.08 Thousand AUD | 53.47% |
| 1999 | 142.1 Thousand AUD | -12.25% |
| 1998 | 161.93 Thousand AUD | -3.19% |
| 1997 | 167.26 Thousand AUD | 75.54% |
| 1996 | 95.28 Thousand AUD | 38.32% |
| 1995 | 68.88 Thousand AUD | 114.27% |
| 1994 | 32.15 Thousand AUD | 50.41% |
| 1993 | 21.37 Thousand AUD | -44.97% |
| 1992 | 38.84 Thousand AUD | 33.29% |
| 1991 | 29.14 Thousand AUD | 14.81% |
| 1990 | 25.38 Thousand AUD | -26.92% |
| 1989 | 34.73 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 213.41 Million USD | 0.0% |
| 2024 FY | 264.6 Million USD | 68.56% |
| 2024 Q4 | 264.6 Million USD | 0.0% |
| 2023 FY | 156.98 Million USD | 794.37% |
| 2023 Q4 | 156.98 Million USD | 0.0% |
| 2023 Q2 | 143.83 Million USD | 0.0% |
| 2022 FY | 17.55 Million USD | 321.89% |
| 2022 Q2 | 12.3 Million USD | 0.0% |
| 2022 Q4 | 12.06 Million USD | 0.0% |
| 2021 Q2 | 15.62 Million USD | 0.0% |
| 2021 Q4 | 3.12 Million USD | 0.0% |
| 2021 FY | 4.16 Million USD | -41.23% |
| 2020 FY | 7.07 Million AUD | 8.23% |
| 2020 Q4 | 7.07 Million AUD | 0.0% |
| 2020 Q2 | 6.65 Million AUD | 0.0% |
| 2019 Q2 | 9.26 Million AUD | 0.0% |
| 2019 Q4 | 6.54 Million AUD | 0.0% |
| 2019 FY | 6.54 Million AUD | -17.24% |
| 2018 Q4 | 7.9 Million AUD | 0.0% |
| 2018 FY | 7.9 Million AUD | 285.02% |
| 2017 Q4 | 1.57 Million AUD | 0.0% |
| 2017 FY | 2.05 Million AUD | -1.05% |
| 2016 FY | 2.07 Million AUD | 15.03% |
| 2016 Q4 | 1.54 Million AUD | 0.0% |
| 2015 FY | 1.8 Million AUD | -3.36% |
| 2015 Q4 | 1.8 Million AUD | 0.0% |
| 2014 FY | 1.86 Million AUD | -0.4% |
| 2014 Q4 | 1.86 Million AUD | 0.0% |
| 2013 Q4 | 1.87 Million AUD | 0.0% |
| 2013 FY | 1.87 Million AUD | -23.98% |
| 2012 Q4 | 2.46 Million AUD | 0.0% |
| 2012 FY | 2.46 Million AUD | -13.9% |
| 2011 FY | 2.86 Million AUD | 18.25% |
| 2011 Q4 | 2.86 Million AUD | 0.0% |
| 2010 Q4 | 2.42 Million AUD | 0.0% |
| 2010 FY | 2.42 Million AUD | 19.69% |
| 2009 FY | 2.02 Million AUD | -13.55% |
| 2009 Q4 | 2.02 Million AUD | 0.0% |
| 2008 FY | 2.33 Million AUD | -53.2% |
| 2008 Q4 | 2.33 Million AUD | 0.0% |
| 2007 Q4 | 4.99 Million AUD | 0.0% |
| 2007 FY | 4.99 Million AUD | 190.63% |
| 2006 FY | 1.71 Million AUD | -59.9% |
| 2006 Q4 | 1.71 Million AUD | 0.0% |
| 2005 FY | 4.28 Million AUD | 1273.22% |
| 2005 Q4 | 4.28 Million AUD | 0.0% |
| 2004 Q4 | 312.33 Thousand AUD | 0.0% |
| 2004 FY | 312.33 Thousand AUD | -1.86% |
| 2003 Q4 | 318.25 Thousand AUD | 0.0% |
| 2003 FY | 318.25 Thousand AUD | 52.37% |
| 2002 FY | 208.87 Thousand AUD | 25.94% |
| 2002 Q4 | 209.09 Thousand AUD | 0.0% |
| 2001 FY | 165.84 Thousand AUD | -23.95% |
| 2001 Q4 | 165.89 Thousand AUD | 0.0% |
| 2000 FY | 218.08 Thousand AUD | 53.47% |
| 2000 Q4 | 218.08 Thousand AUD | 0.0% |
| 1999 FY | 142.1 Thousand AUD | -12.25% |
| 1999 Q4 | 94.86 Thousand AUD | 0.0% |
| 1998 FY | 161.93 Thousand AUD | -3.19% |
| 1997 Q4 | 126.05 Thousand AUD | 0.0% |
| 1997 FY | 167.26 Thousand AUD | 75.54% |
| 1996 FY | 95.28 Thousand AUD | 38.32% |
| 1995 FY | 68.88 Thousand AUD | 114.27% |
| 1994 FY | 32.15 Thousand AUD | 50.41% |
| 1993 FY | 21.37 Thousand AUD | -44.97% |
| 1992 FY | 38.84 Thousand AUD | 33.29% |
| 1991 FY | 29.14 Thousand AUD | 14.81% |
| 1990 FY | 25.38 Thousand AUD | -26.92% |
| 1989 FY | 34.73 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -6156.614% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -86131.76% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -2727.968% |
| Biome Australia Limited | 5.37 Million AUD | -4824.406% |
| Patrys Limited | 691.36 Thousand AUD | -38172.301% |
| Orthocell Limited | 22.08 Million AUD | -1098.232% |
| Imugene Limited | 33.14 Million AUD | -698.353% |
| Noxopharm Limited | 1.28 Million AUD | -20433.79% |
| PYC Therapeutics Limited | 10.18 Million AUD | -2498.183% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -1966.699% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -11277.946% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -16173.893% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -22495.121% |
| CSL Limited | 27.88 Billion AUD | 99.051% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -12765.733% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -71715.488% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | -841.234% |
| Starpharma Holdings Limited | 8.69 Million AUD | -2942.094% |
| Nanollose Limited | 465.64 Thousand AUD | -56724.927% |
| Memphasys Limited | 5.59 Million AUD | -4631.451% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -61202.804% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -308714.226% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -7621.529% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -6989.921% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -25205.587% |
| Race Oncology Limited | 1.91 Million AUD | -13707.026% |
| Nyrada Inc. | 855.63 Thousand AUD | -30824.625% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | -6.099% |
| Dimerix Limited | 13.89 Million AUD | -1804.56% |
| PharmAust Limited | 896.6 Thousand AUD | -29411.402% |
| Immutep Limited | 10.97 Million AUD | -2309.935% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -3075.816% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -4776.827% |
| BTC Health Limited | 203.94 Thousand AUD | -129639.587% |
| Acrux Limited | 5.68 Million AUD | -4552.739% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | -518.762% |
| Biotron Limited | 737.5 Thousand AUD | -35777.752% |
| Tissue Repair Ltd | 1.35 Million AUD | -19486.98% |
| AdAlta Limited | 3.54 Million AUD | -7369.222% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | -492.174% |
| Hexima Limited | 248.67 Thousand AUD | -106306.6% |
| AnteoTech Limited | 4.07 Million AUD | -6392.874% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -7282.146% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | -1564.852% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -28003.033% |
| Actinogen Medical Limited | 1.61 Million AUD | -16280.249% |
| Immuron Limited | 2.84 Million AUD | -9215.225% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -10803.66% |